AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder Cancer

• click to rate

  Posted by Two Blokes May 27, 2025 - Filed in Stock - 6 views
  
  AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study.